Anti-NQO2 Antibody

This polyclonal reagent from Antibodies.com targets NQO2 (NAD(P)H:quinone oxidoreductase 2), a cytosolic flavoenzyme of roughly 25.9 kDa that catalyzes the two-electron reduction of quinones and related electrophilic substrates. Raised in rabbit and supplied as an unconjugated 100 µl aliquot, the antibody is validated for western blot, immunohistochemistry, and immunofluorescence workflows on human, mouse, and rat specimens.

NQO2 is studied widely in cancer biology, neurodegeneration, and oxidative-stress research, where it has been linked to melatonin metabolism, detoxification pathways, and models of Parkinson's disease. Investigators commonly deploy this reagent to map NQO2 distribution in liver, kidney, and neural tissues, and the polyclonal format provides broader epitope coverage than monoclonal alternatives when expression levels are low or variable. Storage is at -20 °C in working aliquots to limit freeze-thaw damage. The product is for research use only and is not intended for diagnostic applications.